- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 435271, 12 pages
Facilitated Cross-Bridge Interactions with Thin Filaments by Familial Hypertrophic Cardiomyopathy Mutations in α-Tropomyosin
1Department of Biological Science, The Florida State University, Tallahassee, FL 32306-4295, USA
2Department of Neurobiology, College of Basic Medical Science, Southern Medical University, Guangzhou 510515, China
3Donders Institute for Brain, Cognition and Behavior, Centre for Cognitive Neuroimaging, Radboud University Nijmegen, 6500 HB Nijmegen, The Netherlands
4Department of Biology, American University in Cairo, Cairo 11835, Egypt
5Department of Biomedical Sciences, The Florida State University College of Medicine, Tallahassee, FL 32306, USA
6Institute of Molecular Biophysics, The Florida State University, Tallahassee, FL 32306, USA
7Department of Mathematics, The Florida State University, Tallahassee, FL 32306, USA
8Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA
9QIAGEN Inc., Valencia, CA 91355, USA
10Department of Physics, The Florida State University, Tallahassee, FL 32306, USA
11Hitachi Global Storage Technologies, San Jose Research Center, San Jose, CA 95135, USA
12Agilent Technologies Inc., Santa Clara, CA 95051, USA
Received 1 June 2011; Accepted 24 August 2011
Academic Editor: Guy Benian
Copyright © 2011 Fang Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. A. Towbin and N. E. Bowles, “The failing heart,” Nature, vol. 415, no. 6868, pp. 227–233, 2002.
- C. S. Redwood, J. C. Moolman-Smook, and H. Watkins, “Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy,” Cardiovascular Research, vol. 44, no. 1, pp. 20–36, 1999.
- D. Fatkin and R. M. Graham, “Molecular mechanisms of inherited cardiomyopathies,” Physiological Reviews, vol. 82, no. 4, pp. 945–980, 2002.
- M. S. Parmacek and R. J. Solaro, “Biology of the troponin complex in cardiac myocytes,” Progress in Cardiovascular Diseases, vol. 47, no. 3, pp. 159–176, 2004.
- F. Ahmad, J. G. Seidman, and C. E. Seidman, “The genetic basis for cardiac remodeling,” Annual Review of Genomics and Human Genetics, vol. 6, pp. 185–216, 2005.
- K. Elliott, H. Watkins, and C. S. Redwood, “Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy,” Journal of Biological Chemistry, vol. 275, no. 29, pp. 22069–22074, 2000.
- E. Homsher, D. M. Lee, C. Morris, D. Pavlov, and L. S. Tobacman, “Regulation of force and unloaded sliding speed in single thin filaments: effects of regulatory proteins and calcium,” Journal of Physiology, vol. 524, no. 1, pp. 233–243, 2000.
- J. Köhler, Y. Chen, B. Brenner et al., “Familial hypertrophic cardiomyopathy mutations in troponin I (K183Δ, G203S, K206Q) enhance filament sliding,” Physiological Genomics, vol. 14, pp. 117–128, 2003.
- R. Lang, A. V. Gomes, J. Zhao, P. R. Housmans, T. Miller, and J. D. Potter, “Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy,” Journal of Biological Chemistry, vol. 277, no. 14, pp. 11670–11678, 2002.
- D. Lin, A. Bobkova, E. Homsher, and L. S. Tobacman, “Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy,” Journal of Clinical Investigation, vol. 97, no. 12, pp. 2842–2848, 1996.
- H. L. Sweeney, H. S. Feng, Z. Yang, and H. Watkins, “Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14406–14410, 1998.
- D. Szczesna, R. Zhang, J. Zhao, M. Jones, G. Guzman, and J. D. Potter, “Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy,” Journal of Biological Chemistry, vol. 275, no. 1, pp. 624–630, 2000.
- F. Takahashi-Yanaga, S. Morimoto, K. Harada et al., “Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 12, pp. 2095–2107, 2001.
- L. Thierfelder, H. Watkins, C. MacRae et al., “α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere,” Cell, vol. 77, no. 5, pp. 701–712, 1994.
- A. Karibe, L. S. Tobacman, J. Strand et al., “Hypertrophic cardiomyopathy caused by a novel α-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis,” Circulation, vol. 103, no. 1, pp. 65–71, 2001.
- A. M. Gordon, Y. Chen, B. Liang, M. LaMadrid, Z. Luo, and P. B. Chase, “Skeletal muscle regulatory proteins enhance F-actin in vitro motility,” Advances in Experimental Medicine and Biology, vol. 453, pp. 187–197, 1998.
- P. VanBuren, K. A. Palmiter, and D. M. Warshaw, “Tropomyosin directly modulates actomyosin mechanical performance at the level of a single actin filament,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 22, pp. 12488–12493, 1999.
- S. V. Perry, “Vertebrate tropomyosin: distribution, properties and function,” Journal of Muscle Research and Cell Motility, vol. 22, no. 1, pp. 5–49, 2001.
- A. M. Gordon, E. Homsher, and M. Regnier, “Regulation of contraction in striated muscle,” Physiological Reviews, vol. 80, no. 2, pp. 853–924, 2000.
- W. Bing, C. S. Redwood, I. F. Purcell, G. Esposito, H. Watkins, and S. B. Marston, “Effects of two hypertrophic cardiomyopathy mutations in α-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility,” Biochemical and Biophysical Research Communications, vol. 236, no. 3, pp. 760–764, 1997.
- N. Golitsina, Y. An, N. J. Greenfield et al., “Effects of two familial hypertrophic cardiomyopathy-causing mutations on α-tropomyosin structure and function,” Biochemistry, vol. 38, no. 12, p. 3850, 1999.
- M. C. Mathur, P. B. Chase, and J. M. Chalovich, “Several cardiomyopathy causing mutations on tropomyosin either destabilize the active state of actomyosin or alter the binding properties of tropomyosin,” Biochemical and Biophysical Research Communications, vol. 406, no. 1, pp. 74–78, 2011.
- M. J. Heller, M. Nili, E. Homsher, and L. S. Tobacman, “Cardiomyopathic tropomyosin mutations that increase thin filament Ca2+ sensitivity and tropomyosin N-domain flexibility,” Journal of Biological Chemistry, vol. 278, no. 43, pp. 41742–41748, 2003.
- E. Kremneva, S. Boussouf, O. Nikolaeva, R. Maytum, M. A. Geeves, and D. I. Levitsky, “Effects of two familial hypertrophic cardiomyopathy mutations in α-tropomyosin, Asp175Asn and Glut180Gly, on the thermal unfolding of actin-bound tropomyosin,” Biophysical Journal, vol. 87, no. 6, pp. 3922–3933, 2004.
- F. Bai, A. Weis, A. K. Takeda, P. B. Chase, and M. Kawai, “Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations,” Biophysical Journal, vol. 100, no. 4, pp. 1014–1023, 2011.
- W. Bing, A. Knott, C. Redwood et al., “Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle α-tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay,” Journal of Molecular and Cellular Cardiology, vol. 32, no. 8, pp. 1489–1498, 2000.
- R. Bottinelli, D. A. Coviello, C. S. Redwood et al., “A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity,” Circulation Research, vol. 82, no. 1, pp. 106–115, 1998.
- R. Prabhakar, N. Petrashevskaya, A. Schwartz et al., “A mouse model of familial hypertrophic cardiomyopathy caused by a α-tropomyosin mutation,” Molecular and Cellular Biochemistry, vol. 251, no. 1-2, pp. 33–42, 2003.
- R. Prabhakar, G. P. Boivin, I. L. Grupp et al., “A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 10, pp. 1815–1828, 2001.
- P. B. Monteiro, R. C. Lataro, J. A. Ferro, and F. D. C. Reinach, “Functional α-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group,” Journal of Biological Chemistry, vol. 269, no. 14, pp. 10461–10466, 1994.
- B. Schoffstall, N. M. Brunet, S. Williams et al., “Ca2+ sensitivity of regulated cardiac thin filament sliding does not depend on myosin isoform,” Journal of Physiology, vol. 577, no. 3, pp. 935–944, 2006.
- A. M. Gordon, M. A. LaMadrid, Y. Chen, Z. Luo, and P. B. Chase, “Calcium regulation of skeletal muscle thin filament motility in vitro,” Biophysical Journal, vol. 72, no. 3, pp. 1295–1307, 1997.
- S. S. Margossian and S. Lowey, “Preparation of myosin and its subfragments from rabbit skeletal muscle,” Methods in Enzymology, vol. 85, pp. 55–71, 1982.
- J. D. Pardee and J. Aspudich, “Purification of muscle actin,” Methods in Enzymology, vol. 85, pp. 164–181, 1982.
- S. J. Kron, Y. Y. Toyoshima, T. Q. P. Uyeda, and J. A. Spudich, “Assays for actin sliding movement over myosin-coated surfaces,” Methods in Enzymology, vol. 196, pp. 399–416, 1991.
- H. Edelhoch, “Spectroscopic determination of tryptophan and tyrosine in proteins,” Biochemistry, vol. 6, no. 7, pp. 1948–1954, 1967.
- Y. H. Chen, J. T. Yang, and H. M. Martinez, “Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion,” Biochemistry, vol. 11, no. 22, pp. 4120–4131, 1972.
- N. Sreerama and R. W. Woody, “Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set,” Analytical Biochemistry, vol. 287, no. 2, pp. 252–260, 2000.
- G. C. Chen and J. T. Yang, “Two-point calibration of circular dichrometer with d-10-camphorsulfonic acid,” Analytical Letters, vol. 10, pp. 1195–1207, 1977.
- B. Liang, Y. Chen, C. K. Wang et al., “Ca2+ regulation of rabbit skeletal muscle thin filament sliding: role of cross-bridge number,” Biophysical Journal, vol. 85, no. 3, pp. 1775–1786, 2003.
- G. Mihajlović, N. M. Brunet, J. Trbović, P. Xiong, S. Von Molnár, and P. B. Chase, “All-electrical switching and control mechanism for actomyosin-powered nanoactuators,” Applied Physics Letters, vol. 85, no. 6, pp. 1060–1062, 2004.
- N. M. Brunet, G. Mihajlovi ć, K. Aledealat, et al., “Micro-mechanical thermal assays of Ca2+-regulated thin filament function and modulation by hypertrophic cardiomyopathy mutants of human cardiac troponin,” Journal of Biomedicine and Biotechnology. In press.
- E. Homsher, B. Kim, A. Bobkova, and L. S. Tobacman, “Calcium regulation of thin filament movement in an in vitro motility assay,” Biophysical Journal, vol. 70, no. 4, pp. 1881–1892, 1996.
- T. Q. P. Uyeda, S. J. Kron, and J. A. Spudich, “Myosin step size estimation from slow sliding movement of actin over low densities of heavy meromyosin,” Journal of Molecular Biology, vol. 214, no. 3, pp. 699–710, 1990.
- Y. Harada, K. Sakurada, T. Aoki, D. D. Thomas, and T. Yanagida, “Mechanochemical coupling in actomyosin energy transduction studied by in vitro movement assay,” Journal of Molecular Biology, vol. 216, no. 1, pp. 49–68, 1990.
- I. D. C. Fraser and S. B. Marston, “In vitro motility analysis of actin-tropomyosin regulation by troponin and calcium. The thin filament is switched as a single cooperative unit,” Journal of Biological Chemistry, vol. 270, no. 14, pp. 7836–7841, 1995.
- B. Schoffstall, V. A. LaBarbera, N. M. Brunet, et al., “Interaction between troponin and myosin enhances contractile activity of myosin in cardiac muscle,” DNA and Cell Biology. In press.
- D. E. Michele, F. P. Albayya, and J. M. Metzger, “Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant α-tropomyosins in adult cardiac myocytes,” Nature Medicine, vol. 5, no. 12, pp. 1413–1417, 1999.
- D. E. Michele, C. A. Gomez, K. E. Hong, M. V. Westfall, and J. M. Metzger, “Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by β-blockade,” Circulation Research, vol. 91, no. 3, pp. 255–262, 2002.
- E. M. Burkart, G. M. Arteaga, M. P. Sumandea, R. Prabhakar, D. F. Wieczorek, and R. J. Solaro, “Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an α-tropomyosin mutation linked to familial hypertrophic cardiomyopathy,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 10, pp. 1285–1293, 2003.
- D. Wernicke, C. Thiel, C. M. Duja-Isac et al., “α-tropomyosin mutations Asp175 Asn and Glu180 Gly affect cardiac function in transgenic rats in different ways,” American Journal of Physiology, vol. 287, no. 3, pp. R685–R695, 2004.
- A. Lupas, M. Van Dyke, and J. Stock, “Predicting coiled coils from protein sequences,” Science, vol. 252, no. 5010, pp. 1162–1164, 1991.
- T. L. Daniel, A. C. Trimble, and P. B. Chase, “Compliant realignment of binding sites in muscle: transient behavior and mechanical tuning,” Biophysical Journal, vol. 74, no. 4, pp. 1611–1621, 1998.
- D. A. Martyn, P. B. Chase, M. Regnier, and A. M. Gordon, “A simple model with myofilament compliance predicts activation-dependent crossbridge kinetics in skinned skeletal fibers,” Biophysical Journal, vol. 83, no. 6, pp. 3425–3434, 2002.
- P. B. Chase, J. M. Macpherson, and T. L. Daniel, “A spatially explicit nanomechanical model of the half-sarcomere: myofilament compliance affects Ca2+-activation,” Annals of Biomedical Engineering, vol. 32, no. 11, pp. 1559–1568, 2004.
- A. Kataoka, C. Hemmer, and P. B. Chase, “Computational simulation of hypertrophic cardiomyopathy mutations in Troponin I: influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+]i,” Journal of Biomechanics, vol. 40, no. 9, pp. 2044–2052, 2007.
- A. V. Gomes and J. D. Potter, “Molecular and cellular aspects of troponin cardiomyopathies,” Annals of the New York Academy of Sciences, vol. 1015, pp. 214–224, 2004.
- J. H. Brown, K. H. Kim, G. Jun et al., “Deciphering the design of the tropomyosin molecule,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 15, pp. 8496–8501, 2001.
- W. Lehman, V. Hatch, V. Korman et al., “Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments,” Journal of Molecular Biology, vol. 302, no. 3, pp. 593–606, 2000.
- P. Vibert, R. Craig, and W. Lehman, “Steric-model for activation of muscle thin filaments,” Journal of Molecular Biology, vol. 266, no. 1, pp. 8–14, 1997.
- T. Q. P. Uyeda, H. M. Warrick, S. J. Kron, and J. A. Spudich, “Quantized velocities at low myosin densities in an in vitro motility assay,” Nature, vol. 352, no. 6333, pp. 307–311, 1991.
- B. Gafurov, S. Fredricksen, A. Cai, B. Brenner, P. B. Chase, and J. M. Chalovich, “The Δ14 mutation of human cardiac troponin T enhances ATPase activity and alters the cooperative binding of S1-ADP to regulated actin,” Biochemistry, vol. 43, no. 48, pp. 15276–15285, 2004.
- A. V. Gomes and J. D. Potter, “Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene,” Molecular and Cellular Biochemistry, vol. 263, no. 1, pp. 99–114, 2004.